Article Sidebar

Submitted
2 July 2018
Accepted
30 November 2022
Published
14 April 2021
Download
PDF
Statistic
Read Counter : 717 Download : 464

Main Article Content

Abstract

Several studies showed that the index of nasopharyngeal carcinoma (NPC) cell growth could be used to assess the carcinogenesis interaction factor, development and prognosis of NPC. Cell proliferation index could always be assessed with Ki-67 protein expression test. This research was conducted to study the correlation between cell proliferation index with cervical lymphoid node status in NPC in clinical manifestation to asses the progressivity and prognosis on NPC patients. This study used cross sectional design. Biopsy tissue specimen were acquired from 35 NPC patients clinically divided into four criteria of cervical lymphoid node status (N0, N1, N2 and N3). Expression of Ki-67 protein was acquired by immunohistochemistry test using monoclonal rabbit antibody anti-human Ki-67 clone 901-325-091911 (Biocare Medical, LCC. 4040 Pike Line, CA 94520 USA). The measurement of Ki-67 protein was conducted by pathology consultant. Spearman statistic test was performed to asses the correlation between Ki-67 protein expression and cervical lymphoid node status. The statistical significance was defined as p<0.05. Positive expression of Ki-67 protein was found in 33 patients; 4 patients with N0 (11.43%), 5 patients with N1 (14.29%), 9 patients with N2 (25.71%), and 15 patients with N3. Negative expression of Ki-67 protein was found in 2 patients with N0 (5.71%). The Spearman test resulted at p=0.0001 with correlation coefficient of 0.758. The correlation between Ki-67 protein expression with cervical lymphoid node resulted in a significant correlation (p<0.05). In conclusion, cell proliferation index has correlation with cervical lymphoid node status in NPC patients.

Keywords

Nasopharyngeal carcinoma (NPC) cell proliferation index Ki-67 protein expression cervical lymphoid node status

Article Details

License

Copyright (c) 2021 Folia Medica Indonesiana

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

  • Folia Medica Indonesiana is a scientific peer-reviewed article which freely available to be accessed, downloaded, and used for research purposes. Folia Medica Indonesiana (p-ISSN: 2541-1012; e-ISSN: 2528-2018) is licensed under a Creative Commons Attribution 4.0 International License. Manuscripts submitted to Folia Medica Indonesiana are published under the terms of the Creative Commons License. The terms of the license are:

    Attribution ” You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

    NonCommercial ” You may not use the material for commercial purposes.

    ShareAlike ” If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.

    No additional restrictions ” You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

    You  are free to :

    Share ” copy and redistribute the material in any medium or format.

    Adapt ” remix, transform, and build upon the material.

How to Cite
Nugroho, P. S., Yusuf, M., & Hidayati, T. A. (2021). Correlation between Cell Proliferation with Cervical Lymphoid Node Status in Nasopharyngeal Carcinoma Patients. Folia Medica Indonesiana, 57(1), 20–26. https://doi.org/10.20473/fmi.v57i1.8765
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. Li YH, Hu CF, Shao Q, Huang MY, Hou JH, Xie D (2008). Elevated expressions of survival and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma. J Transl Med 6, 1-11.
  2. Taweevisit M, Keelawat S, Thorner PS (2010). Correlation of microvascular density and proliferation index in undifferentiated nasopharyngeal carcinoma. Asian Biomedicine 4, 315-321.
  3. Lin JC (2010). Prognostic factors in nasopharyngeal cancer. In: Lu JJ, Cooper JS, Lee AWM (eds). Nasopharyngeal cancer: multidisciplinary
  4. management, Berlin, Springer-Verlag Berlin Heidelberg, p 95-127.
  5. Taweevisit M (2007). Over-expression of p53 and neoplastic cell proliferation in undifferentiated nasopharyngeal carcinoma.Southeast Asian J Trop Med Public Health 38, 136-140.
  6. Eccles SA (2011). Growth regulatory pathway contributing. In: Lyden D, Welch DR, Psaila B (eds). Cancer metastasis: biologic basis and therapeutics, Cambridge, Cambridge University Press, p 55-85.
  7. Kresno SB (2012). Ilmu dasar onkologi, Jakarta, Fakultas Kedokteran Universitas Indonesia, p 1-89.
  8. Zhuxin W, Shaofeng W (2013). A study on ki67 gene expression and its significance in nasopharyngeal carcinoma. Available from:
  9. http://en.cnki.com.cn/Article_en/CJFDTOTALGXYD200206007.htm. Accessed September 11, 2013.
  10. Liu QY, Han AJ, You SY, Dong Y, Yang QY, Wu JH, Li MF (2008). Correlation of Epstein Barr virusencoded latent membrane protein 1 (LMP1) to fascin and phosphorylated Stat3 in nasopharyngeal
  11. carcinoma. Ai Zheng 27, 1070-1076.
  12. Shi X, Yuan X, Tao D, Gong J, Hu G (2005). Analysis of DNA poidy, cell cycle and Ki67 antigen in nasopharyngeal carcinoma by flow cytometry. J Huazhong Univ Sci Technolog Med Sci 25, 198-201.
  13. Ozel E, Ozbilim G, Dalmaz MG, Guney K (2004). P53 and Ki-67 expression in nasopharyngeal carcinomas. Turkish Journal of Cancer 34, 106-109.
  14. Piris A, Mihm MC C (2007). Mechanisms of metastasis: seed and soil. In: Leong SPL (eds). Cancer metastasis and lymphovascular system: basis for rational therapy, New York, Springer US, p 119-127.
  15. Aswarin R (2014). Hubungan ekspresi protein p53 mutan dengan status kelenjar getah bening regional pada penderita karsinoma nasofaring tipe III. Dalam: Karya Akhir untuk memperoleh ijazah keahlian Ilmu Kesehatan Telinga Hidung Tenggorok Bedah Kepala
  16. dan Leher, Departemen/SMF Ilmu Kesehatan THTKL FK UA/ RSUD Dr Soetomo Surabaya, 2014.
  17. Le QT, Lu JJ (2010). Molecular signaling pathways in nasopharyngeal cancer. In: Lu JJ, Cooper JS, Lee
  18. AWM (eds). Nasopharyngeal cancer: multidisciplinary management, Berlin, SpringerVerlag Berlin Haidelberg, p 27-40.
  19. Harahap MPH (2009). Ekspresi vascular endothelial growth factor pada karsinoma nasofaring. Medan, Universitas Sumatra Utara Repository Medical Records of RSUD Dr Soetomo Surabaya (2014).
  20. National Comprehensive Cancer Network (2011). NCCN clinical practice guideline in oncology (NCCN guideline) head and neck version 2011. Available from: http://ifile.it/3niy4s/_Abeloff_039_s_Clinical_Oncolo
  21. gy_4th_Edition.l_onx341345x98xo9.chm. Accessed September 11, 2013.
  22. Tan PH, Bay BH, Yip G, Selvarajan S, Tan P, Wu J, Lee CH, Li KB (2005). Immunohistochemical detection of Ki67 in breast cancer correlates with transcriptional regulation of genes related to apoptosis
  23. and cell death. Mod Pathol 18, 374-381.
  24. Ma BBY, Poon TCW, Zee B, Mo FKF, Chan CML, Ho S, Teo PML, Johnson PJ, Chan ATC (2003). Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma a prospective study. Head Neck 25, 864-872.
  25. Lavertu P, Adelstein DJ, Myles J, Secic M (2001). P53 and Ki-67 as outcome predictors for advanced squamous cell cancers of the head and neck treated with chemoradiotherapy. Laryngoscope 111, 1878-